Shares of Celcuity Inc. CELC were up 17% at $10.80 after hours as the U.S. Food and Drug Administration granted Breakthrough Therapy designation for a cancer drug. The designation is Read more
Shares of Celcuity Inc. CELC were up 17% at $10.80 after hours as the U.S. Food and Drug Administration granted Breakthrough Therapy designation for a cancer drug. The designation is Read more